Checkpoint Therapeutics Inc., a Fortress Biotech Company, has named James Oliviero as president and chief executive officer. Mr. Oliviero will also be appointed to Checkpoint’s board. Michael Weiss, will remain as executive chairman. “We are very excited to have James join Checkpoint. James is a seasoned biotech executive with strong operational and financial expertise. James’ experience ranges from capital raising and managing relationships with Wall Street to playing an in...